M11.152
Familial chondrocalcinosis, left hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) deposition disease, is a hereditary joint disorder characterized by the buildup of calcium crystals within the cartilage. When this condition affects the left hip, it can lead to joint pain, stiffness, and reduced mobility. The ICD-10 code M11.152 specifically refers to familial chondrocalcinosis localized to the left hip, indicating a familial or inherited component to the disease process.
Causes & Symptoms
Clinical Causes: Genetic predisposition leading to abnormal cartilage metabolism Inheritance patterns passed down within families Accumulation of calcium pyrophosphate dihydrate crystals in joint cartilage Age-related changes in joint cartilage that may exacerbate crystal deposition Certain metabolic conditions that influence calcium and phosphate balance
Key Symptoms: Joint pain, especially during or after movement Stiffness in the affected hip, particularly after periods of inactivity Swelling or tenderness around the joint Reduced range of motion in the left hip Possible warmth or redness in the joint area
Diagnostic & Treatment
Diagnosis Path: Diagnosis of familial chondrocalcinosis involving the left hip typically involves a combination of clinical evaluation, imaging studies, and laboratory tests. Key approaches include: - **Medical history and physical examination:** Assessing symptoms and family history. - **Imaging tests:** X-rays can reveal calcification within the cartilage, characteristic of chondrocalcinosis. - **Joint aspiration:** Analyzing joint fluid under a microscope to identify calcium pyrophosphate crystals. - **Blood tests:** Checking for metabolic abnormalities that may contribute to crystal formation, such as elevated calcium or phosphate levels. These assessments help differentiate this condition from other forms of arthritis or joint diseases.
Treatment Protocols: Management of familial chondrocalcinosis of the left hip aims to relieve symptoms and prevent joint deterioration. Typical approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation, colchicine to reduce crystal formation, or corticosteroid injections into the joint. - **Physical therapy:** Exercises focusing on maintaining joint mobility and strengthening surrounding muscles. - **Lifestyle modifications:** Weight management and avoiding activities that exacerbate joint stress. - **Surgical intervention:** In advanced cases with significant joint damage, procedures such as hip replacement may be considered. While no cure exists for the condition, these treatment strategies focus on improving quality of life and controlling symptoms.
Clinical Advice & FAQs
Billing Guidance
Is M11.152 a billable ICD-10 code?
Yes, M11.152 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.152?
Clinical documentation must specify the nature of Familial chondrocalcinosis, left hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference